Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Fmnl1em1/Cya
Common Name:
Fmnl1-KO
Product ID:
S-KO-20013
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Fmnl1-KO
Strain ID
KOCMP-57778-Fmnl1-B6J-VB
Gene Name
Fmnl1
Product ID
S-KO-20013
Gene Alias
8030453N10Rik; Fmnl; Fnrl; Frls
Background
C57BL/6JCya
NCBI ID
57778
Modification
Conventional knockout
Chromosome
11
Phenotype
MGI:1888994
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Fmnl1em1/Cya mice (Catalog S-KO-20013) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000042286
NCBI RefSeq
NM_001077698
Target Region
Exon 4~6
Size of Effective Region
~1.9 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Fmnl1, or Formin-like 1, belongs to the formin protein family responsible for cytoskeletal remodeling. It has been implicated in various cellular processes, such as cell migration, proliferation, and invasion, by interacting with signaling pathways like CXCR2, TGF-β1/SMADs, and Rac1 [1-3]. Fmnl1 is expressed in multiple cell types, including hematopoietic cells, T cells, and cancer cells, and is crucial for normal immune function and has significant implications in cancer progression. Genetic models, including gene-knockout (KO) models, are valuable for studying its functions.

In cancer, FMNL1 depletion in multiple cancer cell lines and in vivo models has shown significant impacts. In clear cell renal cell carcinoma (ccRCC), FMNL1 upregulation promotes metastasis via induction of CXCR2, and high expression is associated with poor prognosis. Knockdown of FMNL1 inhibits cell migration in vitro and tumor metastasis in vivo [1]. In non-small cell lung cancer (NSCLC), reducing FMNL1 expression suppresses cell proliferation, migration, invasion, and bone metastasis by reducing TGF-β1 expression [2]. In leukemia cells, FMNL1 depletion decreases cell proliferation, colony formation, migration, and tumor growth of xenografts, and its silencing increases Rac1 activity [3]. In nasopharyngeal carcinoma, depletion of FMNL1 suppresses invadopodia formation, epithelial-mesenchymal transition (EMT), and invasive/metastatic capacities [4]. In glioblastoma multiforme, FMNL1 downregulation suppresses cell migration and invasion, actin fiber assembly, and is an independent predictor of poor prognosis [5]. In breast adenocarcinoma, suppression of FMNL1 protein expression impairs cell adhesion, migration, and invasion [6].

In conclusion, Fmnl1 plays essential roles in cell migration, proliferation, and invasion, with significant implications in cancer progression. KO and other loss-of-function models have been instrumental in revealing these roles, highlighting Fmnl1 as a potential prognostic factor and therapeutic target in multiple cancer types. Additionally, Fmnl1 is associated with T cell migration in the immune system, indicating its broader importance in biological processes [1-4, 6, 7, 9].

References:
1. Zhang, Mei-Fang, Li, Qiu-Li, Yang, Yu-Feng, Cao, Yun, Zhang, Chris Zhiyi. 2020. FMNL1 Exhibits Pro-Metastatic Activity via CXCR2 in Clear Cell Renal Cell Carcinoma. In Frontiers in oncology, 10, 564614. doi:10.3389/fonc.2020.564614. https://pubmed.ncbi.nlm.nih.gov/33324547/
2. Yang, Xing-Yi, Liao, Jun-Jie, Xue, Wu-Rong. 2019. FMNL1 down-regulation suppresses bone metastasis through reducing TGF-β1 expression in non-small cell lung cancer (NSCLC). In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 117, 109126. doi:10.1016/j.biopha.2019.109126. https://pubmed.ncbi.nlm.nih.gov/31387165/
3. Favaro, Patricia, Traina, Fabiola, Machado-Neto, João Agostinho, Ridley, Anne J, Saad, Sara Teresinha Olalla. 2013. FMNL1 promotes proliferation and migration of leukemia cells. In Journal of leukocyte biology, 94, 503-12. doi:10.1189/jlb.0113057. https://pubmed.ncbi.nlm.nih.gov/23801653/
4. Chen, Wen-Hui, Cai, Mu-Yan, Zhang, Jia-Xing, Qian, Chao-Nan, Xie, Dan. 2018. FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1. In Oncogene, 37, 6243-6258. doi:10.1038/s41388-018-0351-8. https://pubmed.ncbi.nlm.nih.gov/30013189/
5. Higa, Nayuta, Shinsato, Yoshinari, Kamil, Muhammad, Yoshimoto, Koji, Arita, Kazunori. 2019. Formin-like 1 (FMNL1) Is Associated with Glioblastoma Multiforme Mesenchymal Subtype and Independently Predicts Poor Prognosis. In International journal of molecular sciences, 20, . doi:10.3390/ijms20246355. https://pubmed.ncbi.nlm.nih.gov/31861134/
6. Miller, Eric W, Blystone, Scott D. 2019. The carboxy-terminus of the formin FMNL1ɣ bundles actin to potentiate adenocarcinoma migration. In Journal of cellular biochemistry, 120, 14383-14404. doi:10.1002/jcb.28694. https://pubmed.ncbi.nlm.nih.gov/30977161/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest